1,1,2,2-Tetrakis(4'-(pyridin-4-yl)-[1,1'-biphenyl]-4-yl)ethene, 97%, 1g

1,2-Bis(4'-methyl-2,2'-bipyridin-4-yl)ethane>96.0%(GC)200mg

1,4,7-Trioxa-10-azacyclododecane, 98%, 100mg

3,7-Dimethylocta-1,6-dien-3-ol, 95.0%, 500ml

(Z)-N-(1-(4-Bromophenyl)-1-chloro-3-oxo-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, 95%, 250mg

N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide>98.0%(GC)1g

1-BUTYL-2-NITROBENZENE, 95%, 25g

(3,4-dimethoxybenzyl)(2-nitrophenyl)amine, 95.0%, 1g

HSA-Lewis X1vial

4'-Nitro-[1,1'-biphenyl]-4-amine, 96%, 100mg

(R)-(1-Ethylpyrrolidin-2-yl)methanamine, 95.0%, 10g

2-Chloro-4-methoxynicotinaldehyde, 95.0%, 10g

2-Methylquinoline-3-carboxylic acid, 95.0%, 5g